boulder tirzepatide Compounded FDA Announced Removal of Tirzepatide

PMID 39817343

Previous medications like Semaglutide (Wegovy/Ozempic) target only GLP-1, while Tirzepatide (Mounjaro/Zepbound) targets GLP-1 and GIP

Both require medical supervision: dose titration, monitoring, and screening for contraindications matter for either molecule

Put it in your household bin

Set the vial aside (you may need it again for future reconstitutions if it's a multi-dose vial)

Serious Risks Glucagon-like peptide-1 receptor agonists (GLP1-RAs), including semaglutide, are linked to an increased risk of serious medical conditions, including: Pancreatitis Gallbladder problems Kidney injury Allergic reactions Pulmonary aspiration during anesthesia Mixing Semaglutide and Alcohol There is no direct interaction between alcohol and semaglutide